Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Interleukin-12p40 in the spinal fluid as a biomarker for clinically isolated syndrome.
Impact of Armodafinil on Cognition in Multiple Sclerosis: A Randomized, Double-blind Crossover Pilot Study.
Hereditary diffuse leukoencephalopathy with spheroids with phenotype of primary progressive multiple sclerosis.
Co-existence of tumefactive MS and hepatitis C: A need for further screening and new therapeutic challenge.
Helicobacter pylori infection might prove the hygiene hypothesis in multiple sclerosis.
Methods for Ex Vivo Analysis of Immune Cell Function from the Central Nervous System.
A New Zealand pilot randomized controlled trial of a web-based interactive self-management programme (MSInvigor8) with and without email support for the treatment of multiple sclerosis fatigue.
Transfer of myelin-reactive th17 cells impairs endogenous remyelination in the central nervous system of cuprizone-fed mice.
New insights in the pathogenesis of multiple sclerosis-role of acrolein in neuronal and myelin damage.
Neuropsychological syndromes in multiple sclerosis.
Cognitive fatigue in individuals with multiple sclerosis undergoing immunoablative therapy and hematopoietic stem cell transplantation.
IL-25 prevents T cell-mediated neurotoxicity by decreasing LFA-1 expression.
Towards patient collaboration in cognitive assessment: Specificity, sensitivity, and incremental validity of self-report.
The efficacy and safety of daclizumab and its potential role in the treatment of multiple sclerosis.
Significant association of interleukin-4 gene intron 3 VNTR polymorphism with susceptibility to knee osteoarthritis.
[Neuromyelitis optica spectrum disorders as initial presentation of Sjögren's syndrome: A case report].
Magnitude and concurrence of anxiety and depression among attendees with multiple sclerosis at a tertiary care Hospital in Oman.
Efficacy of Intravenous Immunoglobulin in Neurological Diseases.
The mechanisms of neurotoxicity and the selective vulnerability of nervous system sites.
miR-27a and miR-214 exert opposite regulatory roles in Th17 differentiation via mediating different signaling pathways in peripheral blood CD4(+) T lymphocytes of patients with relapsing-remitting multiple sclerosis.
Treatment with tanshinone IIA suppresses disruption of the blood-brain barrier and reduces expression of adhesion molecules and chemokines in experimental autoimmune encephalomyelitis.
Cutting Edge: CD99 Is a Novel Therapeutic Target for Control of T Cell-Mediated Central Nervous System Autoimmune Disease.
BENEFIT 8-year results provide further support for the long-term value of early treatment of multiple sclerosis.
Optical coherence tomography angiography of optic nerve head and parafovea in multiple sclerosis.
A Review of the Psychometric Properties of Generic Utility Measures in Multiple Sclerosis.

Pages